Flumatinib is a tyrosine kinase inhibitor and it’s a second-generation TK inhibitor drug against Bcr

Recently, Lilly announced that the US FDA approved the company's development of Reyvow (lasmidit

On August 14th, the FDA approved TB Alliance new fluorine-containing anti-tuberculosis drug Pretoman

To all departments and all employees:According to the related provisions on national holidays &

FluoroPharm will exhibit CPhI North America 2020 in Pennsylvania Convention Center,Philadelphia, PA,

The U.S. Food and Drug Administration today granted accelerated approval to Rozlytrek (entrectinib),

According to the American Chemical and Engineering News (C&EN), the American Chemical Abstracts

Novartis today announced the US Food and Drug Administration (FDA) has approved Piqray® (alpelisib)

UCB announced that the USFDA has approved Nayzilam (midazolam) nasal spray for the acute treatment o

To all departments and employees:According to the related national legal & the actual situation